Keyphrases
End-stage Renal Disease
100%
Drug Therapy
100%
Hemodialysis Patients
100%
Dialysis Treatment
75%
Pharmacokinetics
50%
Pharmacodynamics
50%
Medication Management
50%
Elderly Patients
50%
Renal Failure
50%
Pain Management
25%
Dialysis
25%
Pneumonia
25%
Hospitalized Patients
25%
Active Metabolite
25%
Hypertension
25%
Coronary Artery Disease
25%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
25%
Cardiovascular Disease
25%
Congestive Heart Failure
25%
Renal Transplant
25%
Clinical High Risk
25%
Medicare Population
25%
Influenza-like Illness
25%
Immunological Response
25%
Pain Relief
25%
Aging Process
25%
Dialysis Patients
25%
Vaccination Program
25%
Health Practitioners
25%
Disease States
25%
Infectious Complications
25%
Plethora
25%
Constipation
25%
Normal Renal Function
25%
Uremia
25%
Common Infections
25%
Heart Arrhythmia
25%
Maintenance Hemodialysis Patients
25%
Hepatitis B Infection
25%
Dialyzability
25%
Narcosis
25%
US Medicare
25%
Dialysis Access
25%
Pneumococcal Infections
25%
Opioid Narcotics
25%
End-stage Renal Disease Patients
25%
High Risk of Bleeding
25%
Comorbid Diseases
25%
Response to Vaccination
25%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacotherapy
100%
End Stage Renal Disease
100%
Hemodialysis
100%
Diseases
60%
Pharmacodynamics
40%
Infection
40%
Kidney Failure
40%
Pharmacokinetics
40%
Non-Steroidal Anti-Inflammatory Drug
20%
Active Metabolite
20%
Prevalence
20%
Heart Arrhythmia
20%
Coronary Artery Disease
20%
Hepatitis B
20%
Congestive Heart Failure
20%
Infectious Complication
20%
Narcotic Agent
20%
Constipation
20%
Pneumococcal Infection
20%
Uremia
20%
Cardiovascular Disease
20%